SCHEMBL8430237

SCHEMBL8430237

Oc1ccc2c3c(-c4ccc(Cl)cc4)c-3c(Cc3nnn[nH]3)c2c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 3/20 0.39
ESR2 Q92731 1/20 0.39
MAPT P10636 3/20 0.36
MEN1 O00255 2/20 0.36
CYP1A2 P05177 2/20 0.36
CYP3A4 P08684 2/20 0.36
CYP2D6 P10635 2/20 0.36
CYP2C9 P11712 2/20 0.36
ALOX15 P16050 2/20 0.36
ALOX12 P18054 2/20 0.36
CYP2C19 P33261 2/20 0.36
KMT2A Q03164 2/20 0.36
HTT P42858 2/20 0.36
GAA P10253 1/20 0.36
MAPK1 P28482 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
GPR55 Q9Y2T6 1/20 0.36
ALOX5 P09917 3/20 0.35
WEE1 P30291 1/20 0.34
USP2 O75604 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8430246 0.90 MAP2 (0.36) CYP1A2CYP3A4CYP2C19MAPK1HSD17B10
SCHEMBL8430223 0.86 DHODH (0.33) ALOX12KMT2AMAPK1MAP2K4
SCHEMBL8432049 0.83 CYP19A1 (0.41) MAPTMEN1CYP1A2CYP3A4CYP2D6
SCHEMBL8430303 0.81 MEN1 (0.40) MAPTMEN1KMT2AHTTMAPK1
SCHEMBL7487942 0.68 GPR17 (0.43)
SCHEMBL6505678 0.66 NR1H2 (0.41) MAPTALOX12KMT2AHSP90AB1LMNA
SCHEMBL585840 0.66 CCNE2 (0.33) CDK4CCND1
SCHEMBL7492466 0.64 GPR17 (0.41) ALOX15
SCHEMBL7479114 0.64 GPR84 (0.36)
SCHEMBL4675730 0.63 CHEK2 (0.37) MAPTMEN1KMT2AMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5965619-A ADMINISTERING AN INDENE DERIVATIVE OF GIVEN FORMULA, SUCH AS 1-(2,4,6-TRIMETHOXYBENZYLIDENE)-5-DIMETHYLAMINO-2-METHYL-3-INDENYL ACETIC ACID, TO TREAT PRECANCEROUS LESIONS SUCH AS COLONIC ADENOMATOUS POLYPS; SIDE EFFECT REDUCTION CELL PATHWAYS INC. (US) 1999-10-12 US disclosed